Şahin U - Search Results

1

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC. Walsh EE, et al. Among authors: sahin u. N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14. N Engl J Med. 2020. PMID: 33053279 Free PMC article. Clinical Trial.

2

Serological analysis of human tumor antigens: molecular definition and implications.

Türeci O, Sahin U, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Mol Med Today. 1997 Aug;3(8):342-9. doi: 10.1016/s1357-4310(97)01081-2. Mol Med Today. 1997. PMID: 9269687 Review.

3

Serological identification of human tumor antigens.

Sahin U, Türeci O, Pfreundschuh M. Sahin U, et al. Curr Opin Immunol. 1997 Oct;9(5):709-16. doi: 10.1016/s0952-7915(97)80053-2. Curr Opin Immunol. 1997. PMID: 9368781 Review.

4

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

Krause P, Türeci O, Micke P, Buhl R, Huber C, Sahin U. Krause P, et al. Among authors: sahin u. J Immunol Methods. 2003 Dec;283(1-2):261-7. doi: 10.1016/j.jim.2003.09.014. J Immunol Methods. 2003. PMID: 14659917

5

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Among authors: sahin u. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

6

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Koslowski M, Sahin U, Huber C, Türeci O. Koslowski M, et al. Among authors: sahin u. Hum Mol Genet. 2006 Aug 1;15(15):2392-9. doi: 10.1093/hmg/ddl163. Epub 2006 Jun 29. Hum Mol Genet. 2006. PMID: 16809397

7

Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity.

Wu J, Helftenbein G, Koslowski M, Sahin U, Tureci O. Wu J, et al. Among authors: sahin u. Proteins. 2006 Dec 1;65(4):808-15. doi: 10.1002/prot.21218. Proteins. 2006. PMID: 17022085

8

In silico strategy for detection of target candidates for antibody therapy of solid tumors.

Helftenbein G, Koslowski M, Dhaene K, Seitz G, Sahin U, Türeci O. Helftenbein G, et al. Among authors: sahin u. Gene. 2008 May 15;414(1-2):76-84. doi: 10.1016/j.gene.2008.02.009. Epub 2008 Feb 19. Gene. 2008. PMID: 18358640

9

MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.

Koslowski M, Sahin U, Dhaene K, Huber C, Türeci O. Koslowski M, et al. Among authors: sahin u. Cancer Res. 2008 May 1;68(9):3458-66. doi: 10.1158/0008-5472.CAN-07-5768. Cancer Res. 2008. PMID: 18451174

10

Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.

Koslowski M, Türeci O, Huber C, Sahin U. Koslowski M, et al. Among authors: sahin u. Mol Cancer. 2009 Sep 25;8:77. doi: 10.1186/1476-4598-8-77. Mol Cancer. 2009. PMID: 19781065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters